CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Absorbable Delivery Products for Treatment of Patients with Periprosthetic Infections: Clinical and Cost-Effectiveness

Last updated: April 10, 2017
Project Number: RB1080-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of the surgical implantation of absorbable delivery products for local antibiotic treatment of osteomyelitis in the treatment of patients with periprosthetic infections?
  2. What is the cost-effectiveness of the surgical implantation of absorbable delivery products for local antibiotic treatment of osteomyelitis in the treatment of patients with periprosthetic?

Key Message

One randomized control trial and four non-randomized studies were identified regarding absorbable delivery products for the treatment of patients with periprosthetic infections.